Medicare for the first time will soon begin reimbursing hospitals specifically for the administration of tissue plasminogen activator in ischemic stroke patients, marking "what promises to create a ...

About 87 percent of all strokes are ischemic, meaning they’re caused by a blood clot in the brain. For more than 20 years, the standard of care has been a drug called TPA. But now, some doctors are ...

A new report details the case of a patient on the new experimental Alzheimer's drug, lecanemab, who died after experiencing numerous acute intracerebral hemorrhages during treatment with tissue ...

Oct. 4, 2002 — Tissue plasminogen activator (tPA) appears to be safe for menstruating women, according to a case report and literature review published in the October issue of Stroke. However, doctors ...

Ischemic stroke is a leading cause of death and disability in the Western world. At present, intravenous administration of tissue plasminogen activator within 3 h of symptom onset is the only proven ...

A clotbusting drug commonly used to treat ischemic stroke interacts negatively with a promising anti-inflammatory treatment ...